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ABSTRACT 
Pericardial effusion associated with malignacy has poor prognosis. The prompt identification of 
etiology is mandatory, such that timely management can be performed and survival can be 
increased. However, difficulty in etiology determination is commonly encountered. In this case, 
we report female patient with relapse stage IV breast cancer who develop massive pericardial 
and bilateral pleural effusion. The similar characteristics were found in both effusion fluids, 
however the identification of etiology was not similar. Metastatic cells were found in pleural 
effusion, whereas they were absent in pericardial effusion. 
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INTISARI 
Efusi perikard karena keganasan mempunyai prognosis yang buruk. Identifikasi segera dari 
etiologi merupakan hal yang utama, karena penatalaksanaan yang tepat waktu dapat dilakukan 
dan angka harapan hidup meningkat. Namun, kesulitan penentuan etiologi seringkali 
ditemukan. Pada kasus ini,  dilaporkan seorang wanita dengan kanker payudara stadium IV 
kambuh yang mengalami efusi perikard masif dan efusi pleura bilateran. Kedua efusi 
mempunyai karakteristik yang mirip, namun identifikasi etiologi tidak menunjukkan kesamaan. 
Sel-sel metastase ditemukan pada efusi pleura, namun tidak dijumpai pada efusi perikard.  
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INTRODUCTION 
Malignancy accounts for 10-25% of 
pleural and pericardial effusion. Pericardial 
effusion in malignancy patients comes from 
the malignancy itself or due to non 
malignant process, such as infection, side 
effect of chemotherapy medication or 
radiotherapy, and metastatic lymphatic 
obstruction.
1
 Pericardial effusion due to 
direct metastatic process has an 
unfavorable prognosis. The median survival 
time is five months, according to several 
studies.
1
 Clinicians are encouraged to 
determine the etiology of pericardial 
effusion in patient with malignancy as early 
as possible, such that appropriate treatment 
based on the causative pathology could be 
perfomed timely.  
We described a case of pleural and 
pericardial effusion in woman with relapse 
stage IV breast cancer, the etiology of 
pleural effusion was proven metastatic 
breast cancer whereas that of pericardial 
effusion was unproven of malignancy 
process.  
 
CASE REPORT 
 A 54 year-old woman presented to 
our hospital with the chief complaint of 
progressive dyspnea. She was referred 
from district hospital. She had been 
diagnosed with breast cancer in her left 
breast, confirmed by histopathology 
examination as ductal infiltrative breast 
cancer, three years previously. She had 
had radical mastectomy, 6-cycle adjuvant 
chemotherapy and 30-session 
radiotherapy. From the evaluation after 
chemotherapy and radiotherapy, the tumor 
was vanished. She routinely had had 
medical check-up in the oncology outpatient 
clinics. She was a diabetic patients treated 
with subcutaneous analog insulin.  
 Seven month before current 
admission, she complained the presence of 
multiple lumps in her neck. The biopsy of 
the lump revealed relapse breast cancer 
(ductal carcinoma), with  ER (-), PR (-) and 
Her2 (+++) surface markers. She was 
diagnosed as stage IV relapse breast 
cancer, and treated with chemotherapy 
agents capecitabine and lapatinib. Three 
month afterward, she complained easily 
fatigue and dyspnea on effort. The chest x-
ray examination showed cardiomegaly 
(figure 1).  
The multislice thorax CT scan examination 
showed mixed type pulmonary metastatic 
(subpleural, with nodular and pneumonic 
type metastatic), right sided pleural 
effusion, pericardial effusion and multiple 
lymphadenopathy at axilla region). The 
pleural and pericardial effusion fluids had 
density level of 15 HU (figure 2).  
 
In the current admission, the blood 
pressure was 120/80 mmHg, pulse rate 
was 110 times/minute and regular, 
respiration rate was 28 times/minute and 
axillary temperature was 36.7 C. There was 
no pulsus paradoxus, which indicate there 
was no cardiac tamponade. The thorax 
examination showed, decrease tactile 
fremitus at IV-V intercostal space, dull 
percussion in IV-V intercostal space of right 
thorax region. From auscultation, basic 
respiratory sound was vesicular which was 
decreased combined with egophony in IV-V 
left intercostal space. There was no 
pericardial friction rub. From cardiac 
physical examination, there was 
cardiomegaly but no palpable ictus cordis. 
Right border of the heart was shifted to right 
parasternal. Left border of the heart was 
shifted into VII intercostal space along 
axillary anterior line. In auscultation, no 
muffle heart sound, and no murmur / gallop 
sound.  
From laboratory examination, the 
result was unremarkable, except for 
glucose level of 371 mg/dl. This laboratory 
result could not eliminate the possibility of 
infection because she was also treated by 
capecitabin which had neutropenia effect 
and might mask the fullblown leukocytosis 
due to infection. The electrocardiography 
examination showed sinus tachycardia, 
normal axis and low voltage (figure 3). The 
chest x-ray demonstrated pericardial 
effusion with bilateral pleural effusion 
(figure 4). The transthoracal 
echocardiography showed massive 
pericardial effusion, without echo signs of 
cardiac tamponade (figure 5).  
In the first day of hospitalization, 
the echo-guided subxiphoid access 
pericardiocentesis was performed and 
drained approximately 500 mL of exudative 
fluid from pericardial space (table 1). The 
pericardial effusion fluid cytology-pathology 
examination showed suppurative 
inflammation without sign of malignant 
cells. The result of Gram bacterial staining 
and the acid-fast staining were negative. 
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Figure 1. The chest x-ray examination 
seven month before current admission 
showed cardiomegaly. 
 
 
                                                            
Figure 2. The multislice thorax CT scan 
examination showed mixed type pulmonary 
metastatic (subpleural, with nodular and 
pneumonic type metastatic), right sided 
pleural effusion and pericardial effusion. 
  
 
 
Figure 3. The electrocardiography examination showed sinus tachycardia, normal axis and low 
voltage. 
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The bacterial culture of pericardial 
effusion fluid was also negative. This 
patient was managed with subxiphoid 
pericardial effusion drainage every 8 hours, 
with pericardial fluid production 
approximately 150-200 mL/8 hours.The 
patient was consulted to pulmonologist. The 
pleural effusion drainage / thoracentesis 
was performed. The analysis of pleural 
effusion fluid showed an exudative fluid 
(table 1). An adenosine deaminase level 
was 5.5 (markedly positive if > 30), 
indicated that there was no tuberculosis. 
The bacterial culture of pleural effusion fluid 
resulted in the Staphylococcus epidermidis 
which was sensitive to ciprofloxacin, 
levofloxacin, meropenem, tetracycline, 
vancomicyn, ofloxacin and moxifloxacin. 
The Gram bacterial staining and acid-fast 
staining obtained negative result. The 
cytology-pathology analysis of pleural 
effusion fluid showed suppurative 
inflammation and the presence of malignant 
cells with ductal carcinoma type. This result 
was in accord with the multislice thorax CT 
scan which showed pleural type metastatic. 
From immunological analyze, the anti 
dsDNA and ANA test were negative. The 
antibiotics were given based on the fluids 
analysis.Both the pleural and pericardial 
fluid analysis revealed similar results, which 
indicate an exudative characteristics and 
suppurative infection origin. This result was 
also supported by the result from multislice 
thorax CT scan, which showed both pleural 
and pericardial effusion had similar 
concentration (15 HU). These similar 
characteristics indicated that both effusion 
fluids came from the similar origin. 
However, the malignant cells were only 
found in pleural effusion fluid whereas in 
pericardial fluid was absence despite 
repetitive cytological examination.  
Until ten days hospitalization, the 
accumulation of drainage product of 
pericardial effusion was not subsided 
significantly despite antibiotics treatment for 
alleged etiology of suppurative infection; 
therefore the surgical pericardial window 
was performed by cardiothorax surgeon. 
The patient underwent surgical pericardial 
window and during procedure, 500 mL of 
pleural fluid and 300 mL of pericardial fluid 
were collected. The biopsy of pericardial 
tissue was performed and the pathology 
examination showed fibrosis of connective 
tissue with signs of granulation and chronic  
supurative inflammation, no malignant cells 
were found (Figure 6). The patient was 
transferred to ICU for recovery. 
Unfortunately, three days later the patient 
died in the ICU due to sepsis and 
pneumonia. 
 
 
 
Figure 4. The chest x-ray examination on current admission demonstrated pericardial effusion 
with bilateral pleural effusion. 
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Figure 5. The transthoracal echocardiography showed massive pericardial effusion, 
without echo signs of cardiac tamponade. 
 
 
Table 1. Characteristics of pericardial and pleural effusion fluids based on fluids analysis 
Characteristics Pericardial Effusion Fluid Pleural Effusion Fluid 
protein 4.19 g/dL 3.43 g/dL 
erythrocyte 1.000 cells/mcL 300 cells/mcL 
cells 110 cells/mcL 310 cells/mcL 
glucose 290 mg/dL 251 mg/dL 
LDH 778 U/L 210 U/L 
mononuclear cells 67 % 63 % 
polimorphonuclear  33 %. 33 % 
Rivalta test negative negative 
 
 
Figure 6.  The histopathology of pericardial tissue examination showed a fibrosis of 
connective tissue with signs of granulation and chronic supurative inflammation, no malignant 
cells were found 
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DISCUSSION 
 
 We report a case of 54-year-old 
stage IV breast cancer female patient 
suffered from massive pericardial effusion 
and bilateral pleural effusion. The initial 
treatment was echo-guided 
pericardiocentesis and extended pericardial 
effusion drainage. The pleural effusion was 
evacuated with thoracentesis. Both effusion 
fluids were exudates. The proven etiology 
of both pericardial and pleural effusions 
was suppurative infection. The evidence of 
malignant cells were found in the pleural 
effusion, whereas in pericardial effusion 
and tissue were absence. Antibiotic 
treatment was administered; however the 
pericardial drainage product was not 
reduced significantly. Ultimately, the 
pericardial window with surgery was 
performed to alleviate the pericardial 
effusion.   
The etiology of pericardial effusion 
in developing countries is mostly idiopathic 
(50%), infection (15-30%), malignancy (10-
25%), iatrogenic (15-20%) and autoimmune 
disease (5-15%). Among infection, 
tuberculosis is the common cause of 
pericardial effusion in the developing 
countries, which contribute to about 60% of 
all causes.
2
 As a common etiology, we 
worked up the patients with panels of 
inflammation/infection examination, and 
concluded that there was suppurative 
infection as an etiology of pericardial and 
pleural effusion. Therefore, the antibiotics 
were admistered. However, they failed to 
attenuate the pericardial fluids production.  
A pericardial effusion may be 
assessed with multislice thorax CT scan by 
measuring the level of the attenuation. CT 
attenuation close to that of water (<10 HU) 
suggests a transudative effusion. The CT 
attenuation between 20 to 60 HU indicates 
purulent, malignant, or myxedematous 
effusion. The CT attenuation > 60 HU 
suggest an hemorrhage effusion.
3
 In 
patients with malignant disease, pericardial 
involvement may occur by direct tumor 
invasion or metastatic disease. Multislice 
thorax CT scan is important in treatment 
planning and patient’s follow-up.
2
 In this 
patient, the multislice thorax CT scan 
showed similar CT attenuation in pericardial 
and pleural effusion, indicating similar 
characteristics of effusion fluids and may be 
similar etiology. Purulent/suppurative 
pericarditis is rare, accounting for < 1% of 
cases. The most common organisms were 
staphylococci, streptococci and 
pneumococci, while the predominant 
associated lesions were empyema (50%) or 
pneumonia (33%).
2
 Purulent pericarditis is 
an indication for urgent pericardiocentesis 
which is an accurate tool for diagnosis.
2
 
The fluid may be noticeably 
purulent/suppurative. In this case, the 
suppurative inflammation were detected in 
both effusions and the positive culture was 
found in pleural effusion, however based on 
the bacterial finding we concluded that it 
came from contamination.   
Therapy of pericardial effusion 
should be targeted at the etiology. 
Pericardiocentesis or pericardial effusion 
drainage is indicated for acute cardiac 
tamponade or suspected bacterial and 
neoplastic pericarditis.
2
 A study 
retrospectively evaluated 88 patients who 
presented with pericardial tamponade 
associated with a malignancy. It concluded 
that surgical pericardiotomy with pericardial 
biopsy did not significantly increase 
diagnostic value as compared with the 
cytology-pathology assessment using 
pericardiocentesis.
4
 Surgical pericardiotomy 
also did not improve clinical outcomes in 
comparison with pericardiocentesis and 
was associated with a increased rate of 
complications.
4
 Other study involving 
malignancy cases showed that 
pericardiocentesis associated with higher 
recurrence rate as compared with surgical 
pericardiotomy, however the diagnostic 
yield and overall complication rate did not 
significantly differ.
5
    
 Pericardiocentesis with pericardial 
drainage is safe and effective as the 
primary treatment for pericardial effusion in 
patients with malignancy.
6
 Surgical 
drainage of the pericardium is superior to 
non-surgical approaches for symptom relief, 
reduced effusion recurrence and lower 
morbidity.
7
 In this case, pericardiocentesis 
and pericardial effusion drainage were 
performed initially. However, because of the 
product of pericardial fluid drainage still 
significant  (approximately 150-200 mL/8 
hours), the patient was proceeded to 
surgical pericardial window. The pericardial 
drainage product is recommended to 
reduce until < 30 mL/24 hour to achieve 
adherence of pericardial layers and prevent 
accumulation of pericardial fluid again.
8
 If 
this cannot be achieved, then the surgical 
pericardial window must be performed.
8
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Even after pericardial biopsy, we did not 
find the proof of malignancy etiology of the 
pericardial effusion fluid.    
 
CONCLUSION 
We report a case of 54-year-old 
stage IV breast cancer female patient 
suffered from massive pericardial effusion 
and bilateral pleural effusion. The proven 
etiology of both pericardial and pleural 
effusion is supurative inflammation / 
infection. The evidence of malignant cells 
were found in the pleural effusion, whereas 
in pericardial effusion and tissue were 
absent. Antibiotics treatment was 
administered; however the pericardial 
drainage product was not reduced 
significantly. Ultimately, the pericardial 
window with surgery was performed to 
alleviate the pericardial effusion. 
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